The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact attorney Lee Sandler via email or at (305) 894-1000.

Adalimumab – institution of IPR infringement investigation 337-TA-1296 of adalimumab, processes for manufacturing or relating to same, and products containing same (complainants AbbVie Inc., AbbVie Biotechnology Ltd., and AbbVie Operations Singapore Pte. Ltd.; respondents located in Iceland, Germany, Switzerland, Israel, and the U.S.)

Integrated circuits – new patent infringement investigation 337-TA-1295 of integrated circuit products and devices containing same (complainant Future Link Systems LLC; respondents located in Cayman Islands, Taiwan, Hong Kong, and the U.S.)

Video processors – institution of patent infringement investigation 337-TA-1297 of video processing devices, components thereof, and digital smart televisions containing the same

Water filters – new patent infringement investigation 337-TA-1294 of high-performance gravity-fed water filters and products containing the same (complainant Brita LP; respondents located in China, Germany, and the U.S.)

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.